Cord Blood Stem Cells Information

Molecular Medicine Today News

Pioneering engineer elected into prestigious Institute of MedicineTuesday, October 14, 2008 @ 9:20AM( University of Texas at Austin ) Nicholas A. Peppas was elected today to the Institute of Medicine of the National Academy of Sciences, becoming the first faculty member from The University of Texas at Austin to receive this honor -- the highest recognition a scientist or engineer in the medical sciences can receive in the United States.

RXi Pharmaceuticals Obtains an Exclusive Worldwide License to Technology for the Oral Delivery of RNAi Therapeutics ...Tuesday, October 14, 2008 @ 8:21AMRXi Pharmaceuticals Corporation (Nasdaq: RXII), a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that it has licensed exclusive worldwide rights from the University of Massachusetts Medical School (UMMS) to certain technology for the oral delivery of RNAi therapeutics. The technology was ...

Impressive Regenerative Capacity Exhibited By Embryonic HeartTuesday, October 14, 2008 @ 8:08AMA new study demonstrates that the embryonic mouse heart has an astounding capacity to regenerate, a phenomenon previously observed only in non-mammalian species.

ImmunoCellular Therapeutics Appoints Drs. Peter Brooks and Sherie Morrison to Scientific Advisory BoardTuesday, October 14, 2008 @ 8:00AM LOS ANGELES----ImmunoCellular Therapeutics, Ltd. , a biotechnology company, announced today that it has appointed Peter Brooks, Ph.D. and Sherie Morrison, Ph.D. to the company’s Scientific Advisory Board.

Mark Sutherland Joins GenVault as Senior Vice President, Business DevelopmentTuesday, October 14, 2008 @ 8:00AM GenVault Corporation today announces that Mr. Mark Sutherland has joined GenVault as its Senior Vice President of Business Development.

RXi Pharmaceuticals Obtains an Exclusive Worldwide License to Technology for the Oral Delivery of RNAi Therapeutics ...Tuesday, October 14, 2008 @ 7:30AM WORCESTER, Mass.----RXi Pharmaceuticals Corporation , a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference , today announced that it has licensed exclusive worldwide rights from the University of Massachusetts Medical School to certain technology for the oral delivery of RNAi therapeutics.

Nutritional Products International Appoints Dan Rico to Head Medical SalesMonday, October 13, 2008 @ 9:06AM Nutritional Products International announced today that it has appointed Mr. Dan Rico as Vice President of Medical Sales.

Abbott Opens New Research Facility And Pilot Plant In LudwigshafenMonday, October 13, 2008 @ 3:13AMAbbott, recently announced the opening of new development laboratories and a pilot plant facility that will research groundbreaking technologies and test large-scale production of newly developed drug formulations.

Molecular Biology Meets Clinical Research In New JournalSunday, October 12, 2008 @ 1:06PMThe European Molecular Biology Organization (EMBO) proudly announces the introduction of EMBO Molecular Medicine, a new journal dedicated to a research discipline focused on the interface between molecular biology and clinical research.